Showing results (81-90 of 349) with videos related to
Sort By:
Pageof 35
The European Respiratory Journal|February 25, 2012
24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroidsJan Lötvall, Eric D Bateman, Eugene R Bleecker, et al.The Journal of Allergy and Clinical Immunology|March 9, 2005
Polymorphisms in SPINK5 are not associated with asthma in a Dutch populationHajo Jongepier, Gerard H Koppelman, Ilja M Nolte, et al.The Journal of Allergy and Clinical Immunology|March 4, 2009
The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroidsGregory A Hawkins, Ross Lazarus, Richard S Smith, et al.The European Respiratory Journal|October 19, 2013
Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthmaPaul M O'Byrne, Eugene R Bleecker, Eric D Bateman, et al.The Journal of Allergy and Clinical Immunology|August 12, 2017
More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) IIBradley E Chipps, Tmirah Haselkorn, Brandee Paknis, et al.Journal of Negative Results in Biomedicine|June 15, 2014
Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroidsJan Lötvall, Eric D Bateman, William W Busse, et al.The New England Journal of Medicine|September 1, 2016
Serious Asthma Events with Budesonide plus Formoterol vs. Budesonide AloneStephen P Peters, Eugene R Bleecker, Giorgio W Canonica, et al.Chest|January 19, 2010
COPD is associated with a macrophage scavenger receptor-1 gene sequence variationJill A Ohar, Raymond F Hamilton, Siqun Zheng, et al.The Lancet. Respiratory Medicine|May 15, 2016
Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studiesHector G Ortega, Steven W Yancey, Bhabita Mayer, et al.ERJ Open Research|September 23, 2020
Response to mepolizumab treatment is sustained across 4-weekly dosing periodsIan D Pavord, Eugene R Bleecker, Roland Buhl, et al.Pageof 35